First-line Immunotherapy in Metastatic Urothelial Carcinoma

Pooja Ghatalia; Matthew Zibelman; Daniel M. Geynisman; Elizabeth R. Plimack

doi:10.1016/j.euf.2019.04.015

First-line Immunotherapy in Metastatic Urothelial Carcinoma

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

Update on first-line immunotherapy in metastatic urothelial carcinoma.

Original language	English
Pages (from-to)	45-47
Number of pages	3
Journal	European Urology Focus
Volume	6
Issue number	1
DOIs	https://doi.org/10.1016/j.euf.2019.04.015
State	Published - Jan 15 2020

Keywords

Carcinoma, Transitional Cell/secondary
Humans
Immunotherapy
Urologic Neoplasms/pathology

Access to Document

10.1016/j.euf.2019.04.015

Cite this

@article{b134cd6fb6a6450dbf824944fac8f6f8,

title = "First-line Immunotherapy in Metastatic Urothelial Carcinoma",

abstract = "Update on first-line immunotherapy in metastatic urothelial carcinoma.",

keywords = "Carcinoma, Transitional Cell/secondary, Humans, Immunotherapy, Urologic Neoplasms/pathology",

author = "Pooja Ghatalia and Matthew Zibelman and Geynisman, \{Daniel M.\} and Plimack, \{Elizabeth R.\}",

note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology",

year = "2020",

month = jan,

day = "15",

doi = "10.1016/j.euf.2019.04.015",

language = "English",

volume = "6",

pages = "45--47",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - First-line Immunotherapy in Metastatic Urothelial Carcinoma

AU - Ghatalia, Pooja

AU - Zibelman, Matthew

AU - Geynisman, Daniel M.

AU - Plimack, Elizabeth R.

PY - 2020/1/15

Y1 - 2020/1/15

N2 - Update on first-line immunotherapy in metastatic urothelial carcinoma.

AB - Update on first-line immunotherapy in metastatic urothelial carcinoma.

KW - Carcinoma, Transitional Cell/secondary

KW - Humans

KW - Immunotherapy

KW - Urologic Neoplasms/pathology

UR - https://www.scopus.com/pages/publications/85065594263

U2 - 10.1016/j.euf.2019.04.015

DO - 10.1016/j.euf.2019.04.015

M3 - Comment/debate

C2 - 31103603

AN - SCOPUS:85065594263

SN - 2405-4569

VL - 6

SP - 45

EP - 47

JO - European Urology Focus

JF - European Urology Focus

IS - 1

ER -

First-line Immunotherapy in Metastatic Urothelial Carcinoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this